Incyte (INCY) Announces Data on Monjuvi, FDA Approval for GVHD Drug
https://www.zacks.com/stock/news/2323425/incyte-incy-announces-data-on-monjuvi-fda-approval-for-gvhd-drug?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2323425
Aug 16, 2024 - Incyte???s (INCY) late-stage study on tafasitamab for patients with relapsed or refractory follicular lymphoma meets its goal. FDA approves axatilimab for the treatment of chronic graft-versus-host disease.
0
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
https://www.zacks.com/stock/news/2306186/agilent-a-boosts-dcg-segment-with-new-proteoanalyzer-system?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2306186
Jul 22, 2024 - Agilent (A) unveils its new ProteoAnalyzer system in a bid to strengthen its Diagnostics and Genomics Group segment.
0
INCY or MYGN: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2304678/incy-or-mygn-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2304678
Jul 18, 2024 - INCY vs. MYGN: Which Stock Is the Better Value Option?
0
Company News for July 10, 2024
https://www.zacks.com/stock/news/2299139/company-news-for-july-10-2024?cid=CS-ZC-FT-corporate_summary-2299139
Jul 10, 2024 - Companies In The Article Are:INCY, LW,PATH and HELE
0
Agilent (A) Boosts Reach to Lab Researchers With New Devices
https://www.zacks.com/stock/news/2284910/agilent-a-boosts-reach-to-lab-researchers-with-new-devices?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2284910
Jun 06, 2024 - Agilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell.
0
Company News For May 14, 2024
https://www.zacks.com/stock/news/2273380/company-news-for-may-14-2024?cid=CS-ZC-FT-corporate_summary-2273380
May 14, 2024 - Companies In The Article Are:SQSP,INCY, WBA and GOOG.
0
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
https://www.zacks.com/stock/news/2265278/incyte-s-incy-q1-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2265278
Apr 30, 2024 - Incyte's (INCY) first-quarter 2024 earnings and revenues miss estimates. The company maintains 2024 revenue guidance for its lead drug, Jakafi.
0
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
https://www.zacks.com/stock/news/2262685/biotech-stock-roundup-biib-bmy-s-q1-earnings-incy-s-acquisition-updates-from-vrtx?cid=CS-ZC-FT-analyst_blog|earnings_article-2262685
Apr 25, 2024 - Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
0
Novartis (NVS) to Undertake Job Cuts in Development Department
https://www.zacks.com/stock/news/2253912/novartis-nvs-to-undertake-job-cuts-in-development-department?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2253912
Apr 11, 2024 - Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
0
Agilent (A) is Set for Analytica 2024 With Advanced Products
https://www.zacks.com/stock/news/2252827/agilent-a-is-set-for-analytica-2024-with-advanced-products?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2252827
Apr 09, 2024 - Agilent (A) plans to showcase its new products for analytical laboratories at Analytica 2024, boosting its overall product portfolio.
0
Pages: 12
Page 1